Welcome to Qatar Pharmaceutical Industries.
QPI is a pharmaceutical company headquartered in Doha, Qatar, committed to setting new standards in healthcare and providing people access to high quality medicine.
Short Story About
Qatar Pharmaceutical Industries
QPI is a pharmaceutical company headquartered in Doha, Qatar, committed to setting new standards in healthcare and providing people access to high quality medicine.
QPI offers a wide portfolio of prescription generic, branded generic and over-the-counter remedies, manufactured in world-class facilities, and innovative R&D hub in Doha.
Vision
Our Vision is to be recognized as a leading global drug company by offering a diversified product portfolio of high-quality generics at competitive prices.
Mission
At QPI we are committed to provide the highest possible quality products to the communities we serve so as to enhance and ease the quality of life.
Strategy
Keeping in mind the needs of the people, QPI has dedicated itself to making a clean environment where we prioritize a health aspect of life over any other. We help people aim for a quality life!

Dermatology
Our Clinic and Doctors World over people use massage therapy to help promote healthy skin, nourish and strengthen the body, relieve stress, …

Surgery and Radiology
Operation Rooms With the clinic’s family oriented policies and extremely caring and sympathetic staff, we ensure that each patient is made …

Pediatrics
Children At MedicPress, we provide excellent pediatric care to children in the city and adjacent areas for about half a century now. Our medical …
Qatar Pharmaceutical Industries
has dedicated itself to making a clean environment where we prioritize a health aspect of life over any other.
Manufacturing Facility
A state-of-the-art manufacturing facility of 30,000 sqm of total 60 million U$D, located in the new industrial area in Doha, General OSD & NSL was designed by the top leading professionals in the field of pharmaceutical industry worldwide matching the standards of regulatory authorities worldwide (USFDA, MHRA, EMA..etc) and equipped with cutting-edge equipment to help our team deliver the best possible quality products.
By the end of 2019 phase one (General OSD & NSL) is expected to start commercial production and penetrate the local market with manufacturing capacity exceeds 900,000,000 units annually.
Research and Development
At QPI Research & Development (R&D), we ensure sufficient funding for our R&D activities allocated to research and development to expand our portfolio serving wide number of patients.
Clinic Awards: 

